Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -891.24 Thousand USD | -36.16% |
| 2022 | -654.57 Thousand USD | -2180.82% |
| 2021 | -28.69 Thousand USD | -160.0% |
| 2020 | -11.03 Thousand USD | -4.26% |
| 2019 | -10.58 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -187.18 Thousand USD | 22.76% |
| 2024 Q2 | -193.1 Thousand USD | -3.16% |
| 2023 Q4 | -242.34 Thousand USD | -18.82% |
| 2023 FY | -891.24 Thousand USD | -36.16% |
| 2023 Q2 | -237.09 Thousand USD | -14.06% |
| 2023 Q3 | -203.95 Thousand USD | 13.98% |
| 2023 Q1 | -207.86 Thousand USD | 44.03% |
| 2022 Q4 | -371.38 Thousand USD | -161.56% |
| 2022 Q3 | -141.98 Thousand USD | -70.96% |
| 2022 Q2 | -83.05 Thousand USD | -13.69% |
| 2022 Q1 | -73.05 Thousand USD | -223.95% |
| 2022 FY | -654.57 Thousand USD | -2180.82% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | -28.69 Thousand USD | -160.0% |
| 2021 Q3 | -2649.00 USD | 24.31% |
| 2021 Q2 | -3500.00 USD | 0.0% |
| 2021 Q4 | -22.55 Thousand USD | -751.26% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | -11.03 Thousand USD | -4.26% |
| 2019 FY | -10.58 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 101.583% |
| AngioDynamics, Inc. | 154.69 Million USD | 100.576% |
| AtriCure, Inc. | 300.37 Million USD | 100.297% |
| Avinger, Inc. | 2 Million USD | 144.496% |
| Azenta, Inc. | 263.14 Million USD | 100.339% |
| BioLife Solutions, Inc. | 46.75 Million USD | 101.906% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 100.038% |
| Daxor Corporation | 1.1 Million USD | 180.77% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 109.817% |
| Femasys Inc. | 691.9 Thousand USD | 228.811% |
| GlucoTrack, Inc. | -13 Thousand USD | -6755.754% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 101.464% |
| Hologic, Inc. | 2.22 Billion USD | 100.04% |
| ICU Medical, Inc. | 739.87 Million USD | 100.12% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 100.019% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 105.334% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 100.701% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -646.883% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -646.883% |
| Masimo Corporation | 1 Billion USD | 100.089% |
| Microbot Medical Inc. | -106 Thousand USD | -740.8% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 102.693% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 100.153% |
| Nephros, Inc. | 8.4 Million USD | 110.604% |
| NovoCure Limited | 381.05 Million USD | 100.234% |
| NEXGEL, Inc. | 619 Thousand USD | 243.982% |
| NEXGEL, Inc. | 619 Thousand USD | 243.982% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | -59.722% |
| OraSure Technologies, Inc. | 179.42 Million USD | 100.497% |
| Pro-Dex, Inc. | 14.55 Million USD | 106.125% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 26.16% |
| Predictive Oncology Inc. | 1.14 Million USD | 177.818% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 115.372% |
| QuidelOrtho Corporation | 1.49 Billion USD | 100.06% |
| Repligen Corporation | 315.22 Million USD | 100.283% |
| Sanara MedTech Inc. | 57.13 Million USD | 101.56% |
| STAAR Surgical Company | 252.65 Million USD | 100.353% |
| Utah Medical Products, Inc. | 30.03 Million USD | 102.967% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.043% |
| Jin Medical International Ltd. | 6.78 Million USD | 113.136% |